This guideline covers how to improve services for people aged 14 and above who have been diagnosed as having coexisting severe mental illness and substance misuse. The aim is to provide a range of coordinated services that address people’s wider health and social care needs, as well as other issues suc...
This guideline covers assessing and managing low back pain and sciatica in people aged 16 and over. It outlines physical, psychological, pharmacological and surgical treatments to help people manage their low back pain and sciatica in their daily life. The guideline aims to improve people’s quality of ...
This guideline covers managing spasticity and co-existing motor disorders and their early musculoskeletal complications in children and young people (from birth up to their 19th birthday) with non-progressive brain disorders. It aims to reduce variation in practice and help healthcare professionals to se...
Carson, JL;
Guyatt, G;
Heddle, NM;
Grossman, BJ;
Cohn, CS;
Fung, MK;
Gernsheimer, T;
Holcomb, JB;
Kaplan, LJ;
Katz, LM;
Peterson, N;
Ramsey, G;
Rao, SV;
Roback, JD;
Shander, A;
Tobian, AA.
"IMPORTANCE:
More than 100 million units of blood are collected worldwide each year, yet the indication for red blood cell (RBC) transfusion and the optimal length of RBC storage prior to transfusion are uncertain.
OBJECTIVE:
To provide recommendations for the target hemoglobin level for RBC transfusion...
This guideline covers assessing, diagnosing and managing physical health problems of people in prison. It aims to improve health and wellbeing in the prison population by promoting more coordinated care and more effective approaches to prescribing, dispensing and supervising medicines....
DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the management of gout. METHODS: Using the ACP grading system, the committee based these recommendations on a systematic review of randomized, controlled trials; ...
"OBJECTIVE:
To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes.
PARTICIPANTS:
The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical write...
Glucemia,
Terapia Combinada,
Diabetes Mellitus Tipo 1,
Diabetes Mellitus Tipo 2,
Dieta para Diabéticos,
Monitoreo de Drogas,
Endocrinología,
Hiperglucemia,
Hipoglucemia,
Insulina/uso terapéutico,
Sistemas de Infusión de Insulina,
Monitoreo Ambulatorio,
Educación del Paciente como Asunto,
Medicina de Precisión,
Diabetes Mellitus Tipo 1/tratamiento farmacológico,
Diabetes Mellitus Tipo 2/tratamiento farmacológico,
Diabetes Mellitus Tipo 1/terapia,
Diabetes Mellitus Tipo 2/terapia,
Hipoglucemiantes/uso terapéutico,
Hipoglucemiantes/efectos adversos,
Insulina/efectos adversos
Murray, MJ;
DeBlock, H;
Erstad, B;
Gray, A;
Jacobi, J;
Jordan, C;
McGee, W;
McManus, C;
Meade, M;
Nix, S;
Patterson, A;
Sands, MK;
Pino, R;
Tescher, A;
Arbour, R;
Rochwerg, B;
Murray, CF;
Mehta, S.
"OBJECTIVE:
To update the 2002 version of ""Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient.""
DESIGN:
A Task Force comprising 17 members of the Society of Critical Medicine with particular expertise in the use of neuromuscular-blocking agents; a Gra...
"OBJECTIVE:
To formulate clinical practice guidelines for hormonal replacement in hypopituitarism in adults.
PARTICIPANTS:
The participants include an Endocrine Society-appointed Task Force of six experts, a methodologist, and a medical writer. The American Association for Clinical Chemistry, the Pituit...
Ye, ZK;
Chen, YL;
Chen, K;
Zhang, XL;
Du, GH;
He, B;
Li, DK;
Liu, YN;
Yang, KH;
Zhang, YY;
Zhai, SD.
BACKGROUND: Guideline development should be based on the quality of evidence, balance of benefits and harms, economic evaluation and patients' views and preferences. Therefore, these factors were considered in the development of a new guideline for therapeutic drug monitoring (TDM) of vancomycin. OBJECTI...
